PARD6A
Partitioning defective 6 homolog alpha
Also known as: PAR-6, PAR-6A, PAR6A_HUMAN, PAR6alpha, TAX40, TIP-40
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPB6
- Gene
- PARD6A
- Ensembl
- ENSG00000102981
- Chromosome
- 16
- Canonical length
- 346 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cell Junctions,Actin filaments,Cytosol
OverviewNCBI Gene
This gene is a member of the PAR6 family and encodes a protein with a PSD95/Discs-large/ZO1 (PDZ) domain and a semi-Cdc42/Rac interactive binding (CRIB) domain. This cell membrane protein is involved in asymmetrical cell division and cell polarization processes as a member of a multi-protein complex. The protein also has a role in the epithelial-to-mesenchymal transition (EMT) that characterizes the invasive phenotype associated with metastatic carcinomas. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
346 residues, UniProt reviewed canonical sequence.
>Q9NPB6|PARD6A
1 MARPQRTPAR SPDSIVEVKS KFDAEFRRFA LPRASVSGFQ EFSRLLRAVH QIPGLDVLLG
61 YTDAHGDLLP LTNDDSLHRA LASGPPPLRL LVQKRAEADS SGLAFASNSL QRRKKGLLLR
121 PVAPLRTRPP LLISLPQDFR QVSSVIDVDL LPETHRRVRL HKHGSDRPLG FYIRDGMSVR
181 VAPQGLERVP GIFISRLVRG GLAESTGLLA VSDEILEVNG IEVAGKTLDQ VTDMMVANSH
241 NLIVTVKPAN QRNNVVRGAS GRLTGPPSAG PGPAEPDSDD DSSDLVIENR QPPSSNGLSQ
301 GPPCWDLHPG CRHPGTRSSL PSLDDQEQAS SGWGSRIRGD GSGFSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARD6A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 45 nTPM
- testis: 41 nTPM
- hippocampal formation: 31 nTPM
- cerebral cortex: 31 nTPM
- pituitary gland: 30 nTPM
- pancreas: 27 nTPM
Single-cell type
- late spermatids: 487 nCPM
- early spermatids: 53 nCPM
- late primary spermatocytes: 32 nCPM
- pancreatic islet cells: 32 nCPM
- megakaryocytes: 25 nCPM
- neuroendocrine cells: 20 nCPM
Immune cell
- memory B-cell: 11 nTPM
- naive B-cell: 8.3 nTPM
- MAIT T-cell: 7.9 nTPM
- T-reg: 6.3 nTPM
- memory CD4 T-cell: 5.9 nTPM
- memory CD8 T-cell: 5.4 nTPM
Brain region
- cerebellum: 39 nTPM
- cerebral cortex: 33 nTPM
- hippocampal formation: 30 nTPM
- pons: 27 nTPM
- thalamus: 26 nTPM
- amygdala: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.69
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- cell-cell junction maintenance
- centrosome cycle
- establishment or maintenance of cell polarity
- establishment or maintenance of epithelial cell apical/basal polarity
- positive regulation of protein localization to centrosome
- positive regulation of protein secretion
- regulation of cellular localization
- viral process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARD6A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARD6A as an antibody target. Whether an autoantibody or antibody against PARD6A could matter depends on whether native PARD6A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARD6A is annotated at the cell surface, where native PARD6A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PARD6A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...